Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

SR 144528 MeSH Supplementary Concept Data 2025


MeSH Supplementary
SR 144528
Unique ID
C110630
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C110630
Entry Term(s)
N-(1,3,3-trimethylbicyclo(2.2.1)heptan-2-yl)-5-(4-chloro-3-methylphenyl)-1-(4-methylbenzyl)pyrazole-3-carboxamide
SR-144528
SR144528
Registry Numbers
0
Heading Mapped to
*Camphanes
*Pyrazoles
Frequency
244
Note
a CB2 cannabinoid receptor antagonist; structure in first source
Source
J Pharamcol Exp Ther 1998 Feb;284(2):644-50
Date of Entry
1998/03/04
Revision Date
2007/08/16
SR 144528 Preferred
N-(1,3,3-trimethylbicyclo(2.2.1)heptan-2-yl)-5-(4-chloro-3-methylphenyl)-1-(4-methylbenzyl)pyrazole-3-carboxamide Broader
page delivered in 0.004s